Newsletter | September 23, 2021

09.23.21 -- Raw Material Supplier Change Notifications: New BioPhorum Guidance

Featured Editorial
Industry Insights
How Collaboration Transformed A Generic Into A Best-In-Class New Drug

Learn how a drug developer collaborated to transform a generic API into a commercial sterile injectable approved by regulators.

Approaches To Improve Efficiency In Biopharmaceutical Process Development

Time-to-experiment, time-to-clinic, and time-to-market are becoming even more important for developers and manufacturers of biopharmaceuticals. These tools make process development more efficient.

Embedding Your Drug Strategy Within A Solid Foundation For Success

This white paper looks at the set of trends influencing pharmaceutical development and manufacturing strategy today and how these drivers are influencing new business models with outsourcing partners.

Efficient Transition Of Human Pluripotent Stem Cell Cultures From StemFlex Medium Into NutriStem hPSC XF Medium On Matrigel

Establishing ideal culture methods has been a known challenge in human pluripotent stem cell (hPSC) research since the late 1990s. This paper reviews the suggested method for adapting hPSCs originally cultured in StemFlex to NutriStem hPSC Medium. Read how, for this transition, a simple and direct adaptation can be followed with cultures exhibiting similar morphology as well as higher levels of pluripotency when compared to StemFlex.

News Headlines
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.